DexCom Inc. (0A4M)
LSE
Closed
Sep 15, 2026
Day's Range
84.0452 wk Range
56.00Overview - 0A4M - DexCom Inc.
Key Statistics
Valuation
Enterprise Value
31.50B
P/E (Trailing)
‪1.73‬
PEG Ratio
‪-0.03‬
Price / Book
‪12.22‬
EV / EBITDA
‪22.45‬
Profitability
Gross Margin
‪84.50%‬
Profit Margin
‪20.11%‬
Operating Margin
‪24.32%‬
Return on Assets
‪10.33%‬
Return on Equity
‪38.49%‬
Ownership
Shares Outstanding
305.47M
Float
375.99M
Held by Insiders
‪0.26%‬
Held by Institutions
‪106.45%‬
Price stats
Beta
‪1.41‬
50-Day Avg
‪123.50‬
200-Day Avg
‪113.53‬
Dividends
Frequency
Quarterly
Peers - 0A4M - DexCom Inc.
Peer Comparison
Compared with companies in Medical Devices listed on LSE.
- 0A4MLSEDexCom Inc.+22.69%52-week change1.74P/E (Trailing)‪20.11%‬Profit Margin
- ECORLSEEcora Royalties PLC+48.95%52-week change11.17P/E (Trailing)‪69.39%‬Profit Margin
- AOTILSEAoti Inc.+67.31%52-week change64.17P/E (Trailing)‪4.00%‬Profit Margin
- RUALSERua Life Sciences Plc+62.50%52-week change12.91P/E (Trailing)‪6.10%‬Profit Margin
- 0HKDLSEAxogen, Inc.+61.21%52-week change—P/E (Trailing)‪-13.35%‬Profit Margin
- SINTLSELeverage Shares IncomeShares Intel (INTC) Options ETP+80.28%52-week change—P/E (Trailing)—Profit Margin
- 0QUTLSEEpisurf Medical AB (publ)+56.10%52-week change—P/E (Trailing)‪84.58%‬Profit Margin
Profile Summary - 0A4M - DexCom Inc.
About
DexCom Inc. is a medical device company focused on continuous glucose monitoring systems for diabetes and metabolic health. Dexcom develops wearable biosensors, transmitters, receivers, and software that provide real-time glucose readings, trend data, and alerts to help users and clinicians monitor glucose levels…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
